The Role of Ultrasound-Estimated Bladder-Wall Thickness In the Prediction of Detrusor Overactivity in Patients with Irritative Lower Urinary Tract Symptoms

2012 ◽  
Vol 05 (05) ◽  
Author(s):  
Sabri M Khaled ◽  
Mahamoud M Ali ◽  
Bahaa Elmenshawy ◽  
Hamdy Abozeid ◽  
Mostafa E AbdelMagid
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Wall Thickness ◽  
Detrusor Overactivity ◽  
Lower Urinary Tract ◽  
Bladder Wall ◽  
Bladder Wall Thickness ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals The relationship between bladder wall thickness and lower urinary tract symptoms: Does bladder wall thickness change after alpha-blocker therapy with alfuzosin?

2014 ◽  
Vol 8 (1-2) ◽  
pp. 26 ◽  
Author(s):  
Ayhan Karakose ◽  
Ozgu Aydogdu ◽  
Yusuf Ziya Atesci
Keyword(s):  
Urinary Tract ◽  
Wall Thickness ◽  
Lower Urinary Tract ◽  
Bladder Wall ◽  
Blocker Therapy ◽  
Bladder Wall Thickness ◽  
Urinary Tract Symptoms ◽  
Significant Difference ◽  
Group 2 ◽  
Lower Urinary

Introduction: We evaluate the association between lower urinary tract symptoms (LUTS) and bladder wall thickness (BWT) and investigate whether alfuzosin might improve BWT.Methods: We retrospectively reviewed the data of 164 patients with LUTS. Patients were divided into 2 groups according to BWT(Group 1: BWT ≤5 mm, n = 69; Group 2: BWT >5 mm, n = 95). Age, international prostate symptom score (IPSS), maximum and average urinary flow rates (Qmax and Qave), quality of life (QoL), postvoid residual (PVR) urine volume, prostate volume and prostate-specific antigen (PSA) were compared between the 2 groups. In total, 102 patients underwent transurethral resection of the prostate (TURP) and 62 patients were treated with alfuzosin. We compared BWT, Qmax, Qave, IPSS, QoL, PVR and PSA before and at the sixth month of alfuzosin therapy. A p value of <0.05 was considered statistically significant.Results: The mean BWT of Group 1 was 3.72 ± 0.56 mm and Group 2 was 6.43 ± 1.13 mm. There was a significant difference between the 2 groups in terms of mean Qmax and PVR. There was no statistical difference between the groups in terms of Qave, IPSS, QoL, prostate volume and PSA. There was significant difference between BWT before (6.8 ± 2.1) and after (4.6 ± 1.3) treatment with alfuzosin in 62 patients (p = 0.02). There was a significant difference between pre- and post-treatment values of mean Qmax, Qave, IPSS, QoL score, and PVR with alfuzosin.Conclusion: BWT is a non-invasive and effective test to evaluate patients with lower urinary tract obstruction and may be used for showing the effectiveness of alpha-blocker therapy in patients with LUTS.

scholarly journals Role of frequency volume chart for the assessment of urinary incontinence in men

2018 ◽  
Vol 6 (10) ◽  
pp. 3346
Author(s):  
Debasis Samaddar ◽  
Dilip Kumar Pal
Keyword(s):  
Urinary Incontinence ◽  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Male Patient ◽  
Lower Urinary Tract ◽  
Oral Fluid ◽  
Fluid Intake ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Background: This study was conducted to evaluate the role of FVC (frequency volume chart) in the male patient with urinary incontinence. That will definitely help to evaluate patient’s objective lower urinary tract symptoms including incontinence and guide to manage those symptoms. But there are less number of reported studies showing role of FVC in men with urinary incontinence.Methods: Male patient (19-60 years) presenting with incontinence symptoms from 1st February 2018 to 30th July 2018, were enrolled in the study. They were asked to record the time and volume of each oral fluid intake, voided volume for 3 consecutive days and put tick in the column of incontinence in the FVC if present.Results: Total 205 male patients presented with incontinence symptoms were evaluated, they were divided into 3 age groups (19-32, 33-46 and 47-60 years). Mean incontinence were found 2.65 (19-32 years). 2.99 (33-46 years) and 3.13 (47-60 years). In 47-60 years group total oral fluid intake is positively correlated with frequency (p <0.05) but not in other groups. Correlation of Nocturia with incontinence (p >0.05) and frequency with incontinence (p >0.05) were not statistically significant in any age groups.Conclusions: The FVC is the registration of voiding parameters by patient in his own environment. Assessment of lower urinary tract symptoms based on a history alone is not accurate, value of FVC are found to be consistent and accurate, so it will guide us to initiate management in male with urinary incontinence and also help to assess treatment responsiveness.

Sign in / Sign up

Export Citation Format

Share Document